136 related articles for article (PubMed ID: 1622417)
1. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP
Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
Castor CW; Smith EM; Bignall MC; Hossler PA
J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF
Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
[TBL] [Abstract][Full Text] [Related]
4. Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholipase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture.
Goddard DH; Grossman SL; Newton R; Clark MA; Bomalaski JS
Cytokine; 1992 Sep; 4(5):377-84. PubMed ID: 1420999
[TBL] [Abstract][Full Text] [Related]
5. Polypeptide growth factors augment interleukin 1-induced release of prostaglandin E2 by rheumatoid arthritis synovial cells in vitro.
Goddard DH; Grossman SL; Newton R
Cytokine; 1990 Jul; 2(4):294-9. PubMed ID: 2104229
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
Tai PK; Liao JF; Hossler PA; Castor CW; Carter-Su C
J Biol Chem; 1992 Sep; 267(27):19579-86. PubMed ID: 1527075
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.
Castor CW; Walz DA; Ragsdale CG; Hossler PA; Smith EM; Bignall MC; Aaron BP; Mountjoy K
Biochem Biophys Res Commun; 1989 Sep; 163(2):1071-8. PubMed ID: 2783111
[TBL] [Abstract][Full Text] [Related]
8. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
Castor CW; Miller JW; Walz DA
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368
[TBL] [Abstract][Full Text] [Related]
9. Measurement of beta-thromboglobulin connective tissue activating peptide-III platelet antigen concentrations in pathologic synovial fluids.
Myers SL; Christine TA
J Rheumatol; 1982; 9(1):6-12. PubMed ID: 6177854
[TBL] [Abstract][Full Text] [Related]
10. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.
Inoue H; Takamori M; Nagata N; Nishikawa T; Oda H; Yamamoto S; Koshihara Y
Inflamm Res; 2001 Feb; 50(2):65-72. PubMed ID: 11289656
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator.
Castor CW; Ritchie JC; Williams CH; Scott ME; Whitney SL; Myers SL; Sloan TB; Anderson BE
Arthritis Rheum; 1979 Mar; 22(3):260-72. PubMed ID: 420716
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
Castor CW; Walz DA; Johnson PH; Hossler PA; Smith EM; Bignall MC; Aaron BP; Underhill P; Lazar JM; Hudson DH
J Lab Clin Med; 1990 Oct; 116(4):516-26. PubMed ID: 2212861
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue activation. XXXII. Structural and biologic characteristics of mesenchymal cell-derived connective tissue activating peptide-V.
Cabral AR; Cole LA; Walz DA; Castor CW
Arthritis Rheum; 1987 Dec; 30(12):1393-400. PubMed ID: 3124861
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor.
Myers SL; Castor CW
Arthritis Rheum; 1980 May; 23(5):556-63. PubMed ID: 7378085
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.
Jüngel A; Distler JH; Kurowska-Stolarska M; Seemayer CA; Seibl R; Forster A; Michel BA; Gay RE; Emmrich F; Gay S; Distler O
Arthritis Rheum; 2004 May; 50(5):1468-76. PubMed ID: 15146416
[TBL] [Abstract][Full Text] [Related]
17. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.
Bucala R; Ritchlin C; Winchester R; Cerami A
J Exp Med; 1991 Mar; 173(3):569-74. PubMed ID: 1997647
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue activation. XXXI. Identification of two molecular forms of a human mesenchymal cell-derived growth factor, connective tissue activating peptide-V.
Cabral AR; Castor CW
Arthritis Rheum; 1987 Dec; 30(12):1382-92. PubMed ID: 3325065
[TBL] [Abstract][Full Text] [Related]
19. Regulation of synovial cell growth by polypeptide growth factors.
Goddard DH
DNA Cell Biol; 1992 Apr; 11(3):259-63. PubMed ID: 1567559
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
